Sign In
Buy CNS
$70.20
-1.00 (-1.40%)
At Close: Jun 03, 2026
Cohen & Steers Announces U.S. Wealth Leadership Appointments
09:00am, Tuesday, 14'th Apr 2026
NEW YORK, April 14, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced a series of leadership appointments and organizational enhancements designed to strengthen its U.S. wealth di
MindBio Deploys New Technology Intox Collect™; Expands CNS Drug Detection Capabilities with Voice & Facial Recognition
08:30am, Monday, 13'th Apr 2026
New technology Intox Collect™ has been completed for collection and analysis of voice and facial recognition data using AI for alcohol and a range of new substances that effect the central nervous s
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for March 2026
04:20pm, Thursday, 09'th Apr 2026
NEW YORK, April 9, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $93.1 billion as of March 31, 2026, a decrease of $5.3 billion from ass
Plus Therapeutics Appoints Eric J. Daniels, M.D.
07:30am, Thursday, 09'th Apr 2026
Seasoned biotech executive brings deep experience across clinical development, regulatory strategy, and corporate operations, strengthening execution capabilities as Plus advances REYOBIQ™ and CNS-f
Cohen & Steers, Inc. to Release First Quarter 2026 Results on April 16, 2026
04:20pm, Wednesday, 08'th Apr 2026
NEW YORK, April 8, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced that it expects to release first quarter 2026 results after the market closes on Thursday, April 16, 2026. The earnin
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by
Top 25 High-Yield Dividend Stocks For April 2026
09:42pm, Saturday, 04'th Apr 2026
I present an expanded Top 25 High-Yield dividend stock watchlist for April 2026, targeting quality, value, and long-term return potential. The selected stocks average a 3.86% dividend yield and a proj
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
04:00pm, Monday, 30'th Mar 2026
NEW YORK, March 30, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dis
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
04:00pm, Monday, 30'th Mar 2026
NEW YORK, March 30, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of th
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
04:00pm, Monday, 30'th Mar 2026
NEW YORK, March 30, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources o
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
04:00pm, Monday, 30'th Mar 2026
NEW YORK, March 30, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
04:00pm, Monday, 30'th Mar 2026
NEW YORK, March 30, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sou
JHG or CNS: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 27'th Mar 2026
Investors looking for stocks in the Financial - Investment Management sector might want to consider either Janus Henderson Group plc (JHG) or Cohen & Steers Inc (CNS). But which of these two stocks is
DALLAS--(BUSINESS WIRE)--Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001.
SACRAMENTO, Calif., March 26, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction to acquire blood-brain barrier (BBB)
